Use your antibodies-online credentials, if available.
抗Human TCF3 抗体:
抗Mouse (Murine) TCF3 抗体:
抗Rat (Rattus) TCF3 抗体:
Human Monoclonal TCF3 Primary Antibody for IP, WB - ABIN967433
Bain, Gruenwald, Murre: E2A and E2-2 are subunits of B-cell-specific E2-box DNA-binding proteins. in Molecular and cellular biology 1993
Show all 7 Pubmed References
Human Monoclonal TCF3 Primary Antibody for IP, WB - ABIN967393
Lenardo, Pierce, Baltimore: Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. in Science (New York, N.Y.) 1987
Show all 7 Pubmed References
Human Polyclonal TCF3 Primary Antibody for WB - ABIN151858
Nie, Xu, Vladimirova, Sun: Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. in The EMBO journal 2003
Show all 3 Pubmed References
Human Monoclonal TCF3 Primary Antibody for FACS, ELISA - ABIN1724729
Firulli, Hadzic, McDaid, Firulli: The basic helix-loop-helix transcription factors dHAND and eHAND exhibit dimerization characteristics that suggest complex regulation of function. in The Journal of biological chemistry 2000
Show all 2 Pubmed References
Human Monoclonal TCF3 Primary Antibody for ELISA, WB - ABIN563112
Schmeisser, Grabrucker, Bockmann, Boeckers: Synaptic cross-talk between N-methyl-D-aspartate receptors and LAPSER1-beta-catenin at excitatory synapses. in The Journal of biological chemistry 2009
Human Polyclonal TCF3 Primary Antibody for IHC (p), IHC - ABIN188732
Greenbaum, Lazorchak, Zhuang: Differential functions for the transcription factor E2A in positive and negative gene regulation in pre-B lymphocytes. in The Journal of biological chemistry 2004
This is the first time the protein partners of either E2A-PBX1 (显示 PBX1 抗体) or HOXA9 (显示 HOXA9 抗体) oncoproteins were identified using an unbiased biochemical approach. The identification of translation initiation factors associated with HOXA9 (显示 HOXA9 抗体) might indicate a novel function for HOX (显示 MSH2 抗体) proteins independent of their transcriptional activity.
Poly (ADP-ribose) polymerase (显示 PARP1 抗体) inhibitors selectively induce cytotoxicity in TCF3-HLF (显示 EPAS1 抗体)-positive leukemic cells.
MiR (显示 MLXIP 抗体)-138 may be a tumor suppressor and potential prognostic biomarker in cervical cancer. Its downstream target, TCF3, may also regulate cancer development in a reverse manner as miR (显示 MLXIP 抗体)-138.
High levels of TCF3 in gliomas promote glioma development through the Akt (显示 AKT1 抗体) and Erk (显示 EPHB2 抗体) pathways.
TWIST1 (显示 TWIST1 抗体)-E12 (显示 ELSPBP1 抗体) protein heterodimeric complexes may thus constitute the main active forms of TWIST1 (显示 TWIST1 抗体) with regard to senescence inhibition over the time course of breast tumorigenesis.
Review of the role of the E2A-PBX1 (显示 PBX1 抗体) gene rearrangement in the prognosis of childhood acute lymphoblastic leukemia and its central nervous system relapse.
Our data suggest that E2A antagonism of PU.1 activity contributes to its ability to commit multipotential hematopoietic progenitors to the lymphoid lineages.
E47 is a novel substrate of PAK5 (显示 PAK6 抗体), and PAK5 (显示 PAK6 抗体)-mediated phosphorylation of E47 promotes epithelial-mesenchymal transition. High expression of phospho-E47 was associated with an aggressive phenotype of colon cancer and metastasis.
We observed significant enrichment of the neuroactive ligand-receptor interaction pathway in TCF3-PBX1 (显示 PBX1 抗体) as well as an enrichment of genes involved in immunity and infection pathways in ETV6 (显示 ETV6 抗体)-RUNX1 (显示 RUNX1 抗体) subtype
Over expression of E47 reprograms human pancreatic cancer cells to a quiescent acinar state with reduced tumorigenic potential.
Mechanistic analysis indicated that E47 activated expression of the transcription factor Spi-B (显示 SPIB 抗体) and the suppressor of cytokine signaling 3 (SOCS3 (显示 SOCS3 抗体)), which both downregulated Foxp3 (显示 FOXP3 抗体) expression. These findings demonstrate that the balance of Id3 (显示 ID3 抗体) and E47 controls the maintenance of Foxp3 (显示 FOXP3 抗体) expression in Treg cells and, thus, contributes to Treg cell plasticity.
this study identifies E2A target genes in embryonic neural stem cells and demonstrates that E47 regulates neuronal differentiation via p57(KIP2 (显示 CDKN1C 抗体)).
If Gfi1 (显示 ZNF163 抗体) levels fall below a threshold, Id1 (显示 ID1 抗体) expression increases and renders E2A unable to function, which prevents hematopoietic progenitors from engaging along the B lymphoid lineage
these data identified E2A and E2-2 (显示 TCF4 抗体) as central regulators of B cell immunity.
down-regulation of Id3 (显示 ID3 抗体) in B cells is essential for releasing E2A and E2-2 (显示 TCF4 抗体), which in a redundant manner are required for antigen-induced B cell differentiation.
Data suggest a novel mechanism of drug resistance in which E2a and PRC2 drive changes in the B-cell epigenome; these alterations attenuate alkylating agent treatment-induced apoptosis.
These findings suggest that miR (显示 MLXIP 抗体)-506-3p played an important role in regulating NSC proliferation and differentiation via targeting TCF3 (显示 TCF7L1 抗体), and provide a promising avenue for future in-depth research into the functions of miR (显示 MLXIP 抗体)-506-3p and TCF3 (显示 TCF7L1 抗体) in nervous system development.
Conditional expression of E2A-HLF (显示 HLF 抗体) induces B-cell precursor death and myeloproliferative-like disease in knock-in mice.
Upregulation of E12/E47 by HBx ultimately and concomitant repression of E-cadherin (显示 CDH1 抗体) expression led to epithelial-mesenchymal transition in human hepatocytes.
Mechanistically, E47 repressed the expression of several astrocyte-specific genes in adult NSPCs.
Data indicte that Tcf-1 (显示 HNF1A 抗体) and Lef-1 (显示 LEF1 抗体) exhibit a function in the axis induction assay, which is lacking in Tcf-3 and -4.
This gene encodes a member of the E protein (class I) family of helix-loop-helix transcription factors. E proteins activate transcription by binding to regulatory E-box sequences on target genes as heterodimers or homodimers, and are inhibited by heterodimerization with inhibitor of DNA-binding (class IV) helix-loop-helix proteins. E proteins play a critical role in lymphopoiesis, and the encoded protein is required for B and T lymphocyte development. Deletion of this gene or diminished activity of the encoded protein may play a role in lymphoid malignancies. This gene is also involved in several chromosomal translocations that are associated with lymphoid malignancies including pre-B-cell acute lymphoblastic leukemia (t(1\;19), with PBX1), childhood leukemia (t(19\;19), with TFPT) and acute leukemia (t(12\;19), with ZNF384). Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene, and a pseudogene of this gene is located on the short arm of chromosome 9.
VDR interacting repressor
, class B basic helix-loop-helix protein 21
, helix-loop-helix protein HE47
, immunoglobulin transcription factor 1
, kappa-E2-binding factor
, negative vitamin D response element-binding protein
, transcription factor 3 (E2A immunoglobulin enhancer binding factors E12/E47)
, transcription factor E2-alpha
, transcription factor ITF-1
, vitamin D receptor-interacting repressor
, transcription factor 3
, immunoglobulin enhancer-binding factor E12/E47
, transcription factor A1
, transcription factor E2a
, pancreas specific transcription factor 1c
, transcription regulator Pan
, transcription factor XE12/XE47
, class A basic helix-loop-helix transcription factor G12
, helix-loop-helix protein E12
, helix-loop-helix protein E47
, transcription factor 7-like 1 (T-cell specific, HMG-box)